Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma

by Gillies Stephen D, Kovar Andreas, Gooding William, Whiteside Theresa L, Atkins Michael B, Kirkwood John M, Ribas Antoni, Kashala Oscar, Morse Michael A
Published 2009-07-01

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic...

by Katz Frieder, Balcke Peter, Hawkins Robert, Scheithauer Werner, Dobrowolski Frank, Piedbois Pascal, Herzog Peter, Neyns Bart, Stöger Herbert, Hossfeld Dieter K, Dittrich Christian, Niedergethmann Marco, Raedle Jochen, Oettle Helmut, Langrehr Jan M, Friess Helmut, Vermorken Jan, van Belle Simon, Davidson Neville, Esteve Albert, Castellano Daniel, Kleeff Jörg, Tempia-Caliera Adrien A, Kovar Andreas, Nippgen Johannes
Published 2006-12-01